NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr | ₹116 Cr | ₹112 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹-21 Cr |
Mar2022 | ₹-2.80 Cr |
Mar2021 | ₹-12 Cr |
Mar2020 | ₹116 Cr |
Mar2019 | ₹112 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹-2.80 Cr | Negative | |
Mar2021 | ₹-12 Cr | Negative | |
Mar2020 | ₹116 Cr | 3.84 | |
Mar2019 | ₹112 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹789.5 Cr | 3% | 12% | 99.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | 3% |
12% |
99.7% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses